149Bio is an early stage biotech startup developing novel therapies for GI, Kidney and Fibrotic diseases. Our lab is located in Cambridge Innovation Center (CIC Miami). Our platform technology enables rapid identification and development of novel therapeutics.
At 149Bio, we are striving to make a significant impact on the lives of patients suffering from these diseases with high unmet need. More details coming soon ...